The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project.
anxiety
decision‐making
non‐small cell lung cancer
patient knowledge
treatment consultation
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
May 2024
May 2024
Historique:
revised:
17
03
2024
received:
10
11
2023
accepted:
22
03
2024
medline:
14
5
2024
pubmed:
14
5
2024
entrez:
14
5
2024
Statut:
ppublish
Résumé
To date, lung cancer is one of the most lethal diagnoses worldwide. A variety of lung cancer treatments and modalities are available, which are generally presented during the patient and doctor consultation. The implementation of decision tools to facilitate patient's decision-making and the management of their healthcare process during medical consultation is fundamental. Studies have demonstrated that decision tools are helpful to promote health management and decision-making of lung cancer patients during consultations. The main aim of the present work within the I3LUNG project is to systematically review the implementation of decision tools to facilitate medical consultation about oncological treatments for lung cancer patients. In the present study, we conducted a systematic review following the PRISMA guidelines. We used an electronic computer-based search involving three databases, as follows: Embase, PubMed, and Scopus. 10 articles met the inclusion criteria and were included. They explicitly refer to decision tools in the oncological context, with lung cancer patients. The discussion highlights the most encouraging results about the positive role of decision aids during medical consultations about oncological treatments, especially regarding anxiety, decision-making, and patient knowledge. However, no one main decision aid tool emerged as essential. Opting for a more recent timeframe to select eligible articles might shed light on the current array of decision aid tools available. Future review efforts could utilize alternative search strategies to explore other lung cancer-specific outcomes during medical consultations for treatment decisions and the implementation of decision aid tools. Engaging with experts in the fields of oncology, patient decision-making, or health communication could provide valuable insights and recommendations for relevant literature or research directions that may not be readily accessible through traditional search methods. The development of guidelines for future research were provided with the aim to promote decision aids focused on patients' needs.
Types de publication
Journal Article
Systematic Review
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e7159Subventions
Organisme : European Union's Horizon 2020 caLL topic "HORIZON-HLTH-2021-CARE-05-02 -"
ID : 01057695
Informations de copyright
© 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
Giaquinto AN, Miller KD, Tossas KY, Winn RA, Jemal A, Siegel RL. Cancer statistics for African American/black people 2022. CA Cancer J ClinMay. 2022;72(3):202‐229.
American Cancer Society. About Lung Cancer. American Cancer Society; 2023. https://www.cancer.org/cancer/lung‐cancer/about/keystatistics.html#:~:htmltext=Most%20lung%20cancer%20statistics%20include,%25%20to%2085%25%20are%20NS‐statistics.CLC
Hsieh LY, Chou FJ, Guo SE. Information needs of patients with lung cancer from diagnosis until first treatment follow‐up. PLoS One. 2018a;13(6):e0199515.
Al Achkar M, Marchand L, Thompson M, Chow LQ, Revere D, Baldwin LM. Unmet needs and opportunities for improving care for patients with advanced lung cancer on targeted therapies: a qualitative study. BMJ Open. 2020;10(3):e032639.
Cochrane A, Woods S, Dunne S, Gallagher P. Unmet supportive care needs associated with quality of life for people with lung cancer: a systematic review of the evidence 2007–2020. Eur J Cancer Care. 2022;31(1):e13525.
Hopmans W, Damman OC, Senan S, Hartemink KJ, Smit EF, Timmermans. Patient perspective on shared decision making in stage I non‐small cell lung cancer: a mixed methods study. BMC Cancer. 2015;15:959.
Clark SD, Reuland DS, Brenner AT, Pignone MP. What is the effect of a decision aid on knowledge, values and preferences for lung cancer screening? An online pre–post study. BMJ Open. 2021;11(7):e045160.
Schmidt K, Damm K, Prenzler A, Golpon H, Welte T. Preferences of lung cancer patients for treatment and decision‐making: a systematic literature review. Eur J Cancer Care. 2016;25(4):580‐591.
Fukunaga MI, Halligan K, Kodela J, et al. Tools to promote shared decision‐making in lung cancer screening using low‐dose CT scanning: a systematic review. Chest. 2020;158(6):2646‐2657.
Austin CA, Mohottige D, Sudore RL, Smith AK, Hanson LC. Tools to promote shared decision making in serious illness: a systematic review. JAMA Intern Med. 2015;175(7):1213‐1221.
van Weert J, van Munster BC, Sanders R, Spijker R, Hooft L, Jansen J. Decision aids to help older people make health decisions: a systematic review and meta‐analysis. BMC Med Inform Decis Mak. 2016;16(1):1‐20.
Spronk I, Meijers MC, Heins MJ, et al. Availability and effectiveness of decision aids for supporting shared decision making in patients with advanced colorectal and lung cancer: results from a systematic review. Eur J Cancer Care. 2019;28(3):e13079.
Manners D, Pettigrew S, Lake FR, Piccolo F, McWilliams AM, Brims FJ. Development and evaluation of a consumer information resource, including Patient Decision Aid, for lung cancer screening: a quasi‐experimental study. Transl Behav Med. 2020;10(2):404‐412.
Wheeler P, Murthy U. Experimental methods in decision aid research. Int J Account Inf Syst. 2011;12(2):161‐167.
Durosini I, Triberti S, Savion L, Sebri V, Pravettoni G. The role of emotion‐related abilities in the quality of life of breast cancer survivors: a systematic review. Int J Environ Res Public Health. 2022;19(19):12704. doi:10.3390/ijerph191912704
Beatty L, Kemp E, Butow P, et al. A systematic review of psychotherapeutic interventions for women with metastatic breast cancer: context matters. Psychooncology. 2018;27(1):34‐42.
Brundage MD, Feldman‐Stewart D, Cosby R, et al. Phase I study of a decision aid for patients with locally advanced non‐small‐cell lung cancer. J Clin Oncol. 2001;5:1326‐1335.
Peterson JS, Swire‐Thompson B, Johnson SB. What is the alternative? Responding strategically to cancer misinformation. Future Oncol. 2020;16(25):1883‐1888.
Sebri V, Mazzoni D, Triberti S, Pravettoni G. The impact of unsupportive social support on the injured self in breast cancer patients. Front Psychol. 2021;12:1‐6.
Sebri V, Durosini I, Triberti S, Pravettoni G. The efficacy of psychological intervention on body image in breast cancer patients and survivors: a systematic‐review and meta‐analysis. Front Psychol. 2021;12:611954.
Tian X, Jin Y, Chen H, Tang L, Jiménez‐Herrera MF. Relationships among social support, coping style, perceived stress, and psychological distress in Chinese lung cancer patients. Asia Pac J Oncol Nurs. 2021;8(2):172‐179.
Fiset V, O'Connor AM, Evans W, Graham I, Degrasse C, Logan J. Development and evaluation of a decision aid for patients with stage IV non‐small cell lung cancer. Health Expect. 2000;3:125‐136.
Hollen PJ. Psychometric properties of two instruments to measure quality decision making. Res Nurs Health. 1994;17:137‐148.
Yun YH, Lim CI, Lee ES, et al. Efficacy of health coaching and a web‐based program on physical activity, weight, and distress management among cancer survivors: a multi‐centered randomized controlled trial. Psychooncology. 2020;29(7):1105‐1114.
Leighl NB, Shepherd FA, Zawisza D, et al. Enhancing treatment decision‐making: pilot study of a treatment decision aid in stage IV non‐small cell lung cancer. Br J Cancer. 2008;98(11):1769‐1773.
Myers RE, Advani SM, Myers P, et al. Engaging patients with late‐stage non‐small cell lung cancer in shared decision making about treatment. J Pers Med 11. 2021;11:998.
Ogawa A, Kondo K, Takei H, Fujisawa D, Ohe Y, Akechi T. Decision‐making capacity for chemotherapy and associated factors in newly diagnosed patients with lung cancer. Oncologist. 2018;23:489‐495.
Yılmaz NG, van Weert JCM, Peters E, et al. Testing the effects of modality and narration style on patients' information use in a lung cancer treatment decision aid. Med Decis Mak. 2019;40(8):990‐1002.
Olling K, Stie M, Winther B, Steffensen KD. The impact of a patient decision aid on shared decision‐making behaviour in oncology care and pulmonary medicine‐a field study based on real‐life observations. J Eval Clin Pract. 2019;25:1121‐1130.
Søndergaard SR, Madsen PH, Hilberg O, Jensen KM, Olling K, Steffensen KD. A prospective cohort study of shared decision making in lung cancer diagnostics: impact of using a patient decision aid. Patient Educ Couns. 2019;102:1961‐1968.
Rakovich G. Lung cancer surgery during COVID‐19: keep calm and operate on. J Thorac Dis. 2022;14(12):4574‐4577.
Wu SY, Lazar AA, Gubens MA, et al. Evaluation of a national comprehensive cancer network guidelines‐based decision support tool in patients with non‐small cell lung cancer: a nonrandomized clinical trial. JAMA Netw. 2020;3:e209750.
Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane collaboration's tool for assessing risk of bias in randomized trials. BMJ. 2011;343:d5928.
Coulter A, Entwistle VA, Eccles A, Ryan S, Shepperd S, Perera R. Personalised care planning for adults with chronic or long‐term health conditions. Cochrane Database Syst Rev. 2015;2015(3):CD010523.
Hollen PJ, Gralla RJ, Jones RA, et al. A theory‐based decision aid for patients with cancer: results of feasibility and acceptability testing of DecisionKEYS for cancer. Support Care Cancer. 2013;10:889‐899.
Janis IL, Mann L. Decision making: A psychological analysis of conflict, choice, and commitment. Free press; 1977.
Grisso T, Appelbaum PS, Hill‐Fotouhi C. The MacCAT‐T: a clinical tool to assess patients' capacities to make treatment decisions. Psychiatr Serv. 1997;48:1415‐1419.
Ankolekar A, Dekker A, Fijten R, Berlanga A. The benefits and challenges of using patient decision aids to support shared decision making in health care. JCO Clin Cancer Inform. 2018;2:1‐10.
Cooley ME, Mazzola E, Xiong N, et al. Clinical decision support for symptom management in lung cancer patients: a group RCT. J Pain Symptom Manag. 2022;63(4):572‐580.
Nugent SM, Golden SE, Sullivan DR, et al. Patient‐clinician communication and patient‐centered outcomes among patients with suspected stage I non‐small cell lung cancer: a prospective cohort study. Med Oncol. 2022;39(12):203.
Gordon HS, Pugach O, Solanki P, Gopal RK. A brief pre‐visit educational video improved patient engagement after telehealth visits; results from a randomized controlled trial. PEC Innovation. 2022;1:100080.
Kanazu M, Shimokawa M, Saito R, et al. Predicting systemic therapy toxicity in older adult patients with advanced non‐small cell lung cancer: a prospective multicenter study of National Hospital Organization in Japan. J Geriatr Oncol. 2022;13(8):1216‐1222.
Hauber B, Penrod JR, Gebben D, Musallam L. The value of hope: patients' and physicians' preferences for survival in advanced non‐small cell lung cancer. Patient Prefer Adherence. 2020;14:2093‐2104.
Hofman A, Zajdel N, Klekowski J, Chabowski M. Improving social support to increase QoL in lung cancer patients. Cancer Manag Res. 2021;13:2319‐2327.
Badaoui S, Shahnam A, McKinnon RA, Abuhelwa AY, Sorich MJ, Hopkins AM. The predictive utility of patient‐reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapy. Translational Lung Cancer Research. 2022;11(3):432‐440.
Kutzleben MV, Galuska JC, Hein A, Griesinger F, Ansmann L. Needs of lung cancer patients receiving immunotherapy and acceptance of digital and sensor‐based scenarios for monitoring symptoms at home a qualitative‐explorative study. Int J Environ Res Public Health. 2022;19(15):9265.
Joseph‐Williams N, Lloyd A, Edwards A, et al. Implementing shared decision making in the NHS: lessons from the MAGIC programme. BMJ. 2017;357:j1744.
Lundh A, Knijnenbur SL, Jørgensen AW, van Dalen EC, Kremer LC. Quality of systematic reviews in pediatric oncology–a systematic review. Cancer Treat Rev. 2009;35(8):645‐652.
Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self‐report version of PRIME‐MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. JAMA. 1999;282:1737‐1744.